ARSI overexpression

News alerts, weekly reports and conference planners

Entrez ID:

ARSI overexpression	Squamous Cell Carcinoma of Head and Neck	ARSI overexpression	Squamous Cell Carcinoma of Head and Neck	XAV-939 Sensitive: D – Preclinical XAV-939 Sensitive : D	XAV-939 Sensitive: D – Preclinical XAV-939 Sensitive : D
ARSI overexpression	Squamous Cell Carcinoma of Head and Neck	ARSI overexpression	Squamous Cell Carcinoma of Head and Neck	dasatinib Sensitive: D – Preclinical dasatinib Sensitive : D	dasatinib Sensitive: D – Preclinical dasatinib Sensitive : D
ARSI overexpression	Head and Neck Cancer	ARSI overexpression	Head and Neck Cancer	APO866 Resistant: D – Preclinical APO866 Resistant : D	APO866 Resistant: D – Preclinical APO866 Resistant : D

Associations